At present, there are many types of molecular markers used in clinical diagnosis of BC, among which the main tumor markers are carbohydrate antigen 153, carbohydrate antigen 125, carcinoembryonic antigen, and HER2, whose expression plays a key role in treating BC [14–16]. This evidence concerns the gene ERBB2 and breast cancer.